Vugmeyster, Yulia
Güzel, Gülseren
Hennessy, Meliessa
Loos, Anja H.
Dai, Haiqing
Funding for this research was provided by:
Merck KGaA
Pfizer
EMD Serono
Article History
Received: 23 July 2019
Accepted: 7 August 2019
First Online: 3 September 2019
Compliance with ethical standards
:
: Y. Vugmeyster declares employment and patents with EMD Serono; H. Dai and M. Hennessy declare employment with EMD Serono; G. Güzel declares employment with Merck KGaA; A.H. Loos declares employment, patents, royalties, stock in, or other intellectual property with Merck KGaA.
: All studies were conducted in accordance with the Good Clinical Practice guidelines as defined by the International Conference on Harmonisation and Declaration of Helsinki.
: All patients provided informed consent before starting treatment.